{
  "cells": [
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "4ead8f52",
      "metadata": {
        "id": "4ead8f52",
        "outputId": "21fadb33-2f7c-4ab8-f8ad-db4b54966d83"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Molecule counting : 200\n",
            "Molecule counting : 400\n",
            "Molecule counting : 600\n",
            "Molecule counting : 800\n",
            "Molecule counting : 1000\n",
            "Molecule counting : 1200\n",
            "Molecule counting : 1400\n",
            "Molecule counting : 1600\n",
            "Molecule counting : 1800\n",
            "Molecule counting : 2000\n",
            "Molecule counting : 2200\n",
            "Molecule counting : 2400\n",
            "Molecule counting : 2600\n",
            "Molecule counting : 2800\n",
            "Molecule counting : 3000\n",
            "Molecule counting : 3200\n",
            "Molecule counting : 3400\n",
            "Molecule counting : 3600\n",
            "Molecule counting : 3800\n",
            "Molecule counting : 4000\n",
            "Molecule counting : 4200\n",
            "Molecule counting : 4400\n",
            "Molecule counting : 4600\n",
            "Molecule counting : 4800\n",
            "Molecule counting : 5000\n",
            "Molecule counting : 5200\n",
            "Molecule counting : 5400\n",
            "Molecule counting : 5600\n",
            "Molecule counting : 5800\n",
            "Molecule counting : 6000\n",
            "Molecule counting : 6200\n",
            "Molecule counting : 6400\n",
            "Molecule counting : 6600\n",
            "Molecule counting : 6800\n",
            "Molecule counting : 7000\n",
            "Molecule counting : 7200\n",
            "Molecule counting : 7400\n",
            "Molecule counting : 7600\n",
            "Molecule counting : 7800\n",
            "Molecule counting : 8000\n",
            "Molecule counting : 8200\n",
            "Molecule counting : 8400\n",
            "Molecule counting : 8600\n",
            "Molecule counting : 8800\n",
            "Molecule counting : 9000\n",
            "Molecule counting : 9200\n",
            "Molecule counting : 9400\n",
            "Molecule counting : 9600\n",
            "Molecule counting : 9800\n",
            "Molecule counting : 10000\n",
            "Molecule counting : 10200\n"
          ]
        }
      ],
      "source": [
        "import numpy as np\n",
        "import pandas as pd\n",
        "from chembl_webresource_client.new_client import new_client\n",
        "\n",
        "drug = new_client.drug\n",
        "drugs = drug.filter(warning_type='Withdrawn').only(\"molecule_chembl_id\")\n",
        "df = pd.DataFrame(drugs)\n",
        "\n",
        "mechanism_of_action = []\n",
        "\n",
        "i = 0\n",
        "for el in df['molecule_chembl_id']:\n",
        "    result = new_client.mechanism.filter(molecule_chembl_id = el).only(\"mechanism_of_action\")\n",
        "    \n",
        "    if result[0] !=None:\n",
        "        mechanism_of_action.append(result[0]['mechanism_of_action'])\n",
        "    i = i + 1\n",
        "\n",
        "    if i%200 == 0:\n",
        "        print(f'Molecule counting : {i}')"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "fa2299bb",
      "metadata": {
        "id": "fa2299bb",
        "outputId": "02c3ffc7-39cf-442e-98cb-e82b327ebdab"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Order of the most equal action mechanism : Counter({'Unknown': 177, 'Glucocorticoid receptor agonist': 57, 'DNA inhibitor': 46, 'Epidermal growth factor receptor erbB1 inhibitor': 46, 'Bacterial penicillin-binding protein inhibitor': 38, 'Diagnostic agent': 37, 'Cyclooxygenase inhibitor': 36, 'MAP kinase p38 alpha inhibitor': 34, 'Insulin receptor agonist': 33, 'GABA-A receptor; anion channel positive allosteric modulator': 32, 'Bacterial 70S ribosome inhibitor': 30, 'Hepatocyte growth factor receptor inhibitor': 27, 'Human immunodeficiency virus type 1 reverse transcriptase inhibitor': 23, 'Tubulin inhibitor': 23, 'Dopamine D2 receptor antagonist': 22, 'Sodium channel alpha subunit blocker': 21, 'Peroxisome proliferator-activated receptor alpha agonist': 20, 'Serine/threonine-protein kinase mTOR inhibitor': 20, 'Serotonin 2a (5-HT2a) receptor antagonist': 19, 'Phosphodiesterase 4 inhibitor': 19, 'Supplement': 19, 'Progesterone receptor agonist': 18, 'Vitamin D receptor agonist': 17, 'PI3-kinase class I inhibitor': 17, 'B-lymphocyte antigen CD20 binding agent': 17, 'Bacterial dihydropteroate synthase inhibitor': 16, 'Beta-2 adrenergic receptor agonist': 16, 'Hepatitis C virus serine protease, NS3/NS4A inhibitor': 16, 'Tyrosine-protein kinase BTK inhibitor': 16, 'Cyclooxygenase-2 inhibitor': 15, 'Dual specificity mitogen-activated protein kinase kinase 1 inhibitor': 15, 'Androgen Receptor agonist': 15, 'Serine/threonine-protein kinase AKT inhibitor': 15, 'Histamine H1 receptor antagonist': 14, 'Tyrosine-protein kinase receptor FLT3 inhibitor': 14, 'G protein-coupled receptor 44 antagonist': 14, 'Vanilloid receptor antagonist': 14, 'Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor': 14, 'TNF-alpha inhibitor': 14, 'Fusion glycoprotein F0 inhibitor': 14, 'B-lymphocyte antigen CD19 binding agent': 14, 'PI3-kinase p110-delta subunit inhibitor': 14, 'Thiazide-sensitive sodium-chloride cotransporter inhibitor': 13, 'Tyrosine-protein kinase ABL inhibitor': 13, 'Plasminogen activator': 13, 'Estrogen receptor modulator': 12, 'Androgen Receptor antagonist': 12, 'Cytochrome P450 51 inhibitor': 12, 'Stem cell growth factor receptor inhibitor': 12, 'Fibroblast growth factor receptor inhibitor': 12, 'Voltage-gated L-type calcium channel blocker': 12, 'Dipeptidyl peptidase IV inhibitor': 12, 'Receptor protein-tyrosine kinase erbB-2 inhibitor': 12, 'Programmed cell death protein 1 inhibitor': 12, 'Estrogen receptor alpha agonist': 11, 'Histamine H3 receptor antagonist': 11, 'Type-1 angiotensin II receptor antagonist': 11, 'DNA disrupting agent': 11, 'DNA topoisomerase I inhibitor': 11, 'Neurokinin 1 receptor antagonist': 11, 'Mineralocorticoid receptor antagonist': 11, 'Cell membrane disrupting agent': 11, 'Macrophage colony stimulating factor receptor inhibitor': 11, 'Serine/threonine-protein kinase B-raf inhibitor': 11, 'Bacterial DNA gyrase inhibitor': 10, 'Soluble guanylate cyclase activator': 10, 'Sulfonylurea receptor 1, Kir6.2 blocker': 10, 'DNA cross-linking agent': 10, 'Mu opioid receptor agonist': 10, 'Adenosine A2a receptor antagonist': 10, 'Glucagon-like peptide 1 receptor agonist': 10, 'Androgen Receptor modulator': 10, 'Tyrosine-protein kinase JAK1 inhibitor': 10, 'Erythropoietin receptor agonist': 10, 'Interferon alpha/beta receptor agonist': 10, 'Gonadotropin-releasing hormone receptor antagonist': 9, 'Tubulin stabiliser': 9, 'Vascular endothelial growth factor receptor inhibitor': 9, 'Bile acid receptor FXR agonist': 9, 'Serine/threonine-protein kinase Aurora inhibitor': 9, 'Sodium/glucose cotransporter 2 inhibitor': 9, 'Estrogen receptor agonist': 9, 'Mucin-1 binding agent': 9, 'CD22 binding agent': 9, 'Serine/threonine-protein kinase Chk1 inhibitor': 9, 'Nonstructural protein 5A inhibitor': 9, 'Programmed cell death protein 1 antagonist': 9, 'Endothelin receptor ET-A antagonist': 8, 'Monoamine transporter inhibitor': 8, 'Coagulation factor X inhibitor': 8, 'Serine/threonine-protein kinase Aurora-A inhibitor': 8, 'Heat shock protein HSP90 inhibitor': 8, 'Mu opioid receptor antagonist': 8, 'Calcitonin gene-related peptide type 1 receptor antagonist': 8, 'Vascular endothelial growth factor receptor 2 inhibitor': 8, 'Tyrosine-protein kinase SYK inhibitor': 8, 'Serine/threonine-protein kinase PLK1 inhibitor': 8, 'Antithrombin-III activator': 8, 'Vascular endothelial growth factor A inhibitor': 8, 'Complement C5 inhibitor': 8, 'Tyrosine-protein kinase JAK2 inhibitor': 8, 'Interleukin-6 inhibitor': 8, 'Receptor tyrosine-protein kinase erbB-3 inhibitor': 8, 'C-C chemokine receptor type 2 antagonist': 8, 'Peroxisome proliferator-activated receptor gamma agonist': 7, 'Insulin-like growth factor I receptor inhibitor': 7, 'Serotonin 1a (5-HT1a) receptor agonist': 7, 'Thrombin inhibitor': 7, 'Muscarinic acetylcholine receptor M3 antagonist': 7, 'Glutamate [NMDA] receptor antagonist': 7, 'Angiotensin-converting enzyme inhibitor': 7, 'Serotonin 4 (5-HT4) receptor agonist': 7, 'Neuronal acetylcholine receptor protein alpha-7 subunit agonist': 7, 'Cyclin-dependent kinase 1 inhibitor': 7, 'Adenosine A1 receptor agonist': 7, 'Phosphate sequestering agent': 7, 'Interleukin-13 inhibitor': 7, 'Insulin-like growth factor I receptor antagonist': 7, 'Interleukin 17A inhibitor': 7, 'Growth/differentiation factor 8 inhibitor': 7, 'Carcinoembryonic antigen-related cell adhesion molecule 5 binding agent': 7, 'Dystrophin pre-mRNA positive modulator': 7, 'Lewis Y antigen binding agent': 7, 'Subtilisin/kexin type 9 inhibitor': 7, 'ALK tyrosine kinase receptor inhibitor': 7, 'Sodium channel protein type IX alpha subunit blocker': 7, 'Topoisomerase IV inhibitor': 6, 'FK506-binding protein 1A inhibitor': 6, 'Histamine H2 receptor antagonist': 6, 'Norepinephrine transporter inhibitor': 6, 'Cannabinoid CB1 receptor antagonist': 6, 'Serotonin transporter inhibitor': 6, 'Human immunodeficiency virus type 1 protease inhibitor': 6, 'Voltage-gated T-type calcium channel blocker': 6, 'Beta-3 adrenergic receptor agonist': 6, 'Acetylcholinesterase inhibitor': 6, 'Glutamate receptor ionotropic AMPA antagonist': 6, 'Glucagon receptor agonist': 6, 'Human herpesvirus 1 DNA polymerase inhibitor': 6, 'Rho-associated protein kinase inhibitor': 6, 'Peroxisome proliferator-activated receptor delta agonist': 6, 'Adenosine A1 receptor antagonist': 6, 'Thymidylate synthase inhibitor': 6, 'Prostanoid FP receptor agonist': 6, 'Cholesteryl ester transfer protein inhibitor': 6, 'Peroxisome proliferator-activated receptor gamma modulator': 6, 'Progesterone receptor modulator': 6, 'Inhibitor of nuclear factor kappa B kinase beta subunit inhibitor': 6, 'Cannabinoid CB2 receptor agonist': 6, 'Sodium/potassium-transporting ATPase inhibitor': 6, 'C-X-C chemokine receptor type 4 antagonist': 6, 'Smoothened homolog antagonist': 6, 'Adenosine A2a receptor agonist': 6, 'Focal adhesion kinase 1 inhibitor': 6, 'Granulocyte colony stimulating factor receptor agonist': 6, 'Ig epsilon chain C region inhibitor': 6, 'Bromodomain and extra-terminal motif (BET) inhibitor': 6, 'Glutamate receptor ionotropic AMPA positive allosteric modulator': 6, 'Tumor necrosis factor ligand superfamily member 13B inhibitor': 6, 'Interleukin-23 inhibitor': 6, 'Tumor necrosis factor receptor superfamily member 10B agonist': 6, 'Beta amyloid A4 protein binding agent': 6, 'Glutamate carboxypeptidase II binding agent': 6, 'Toll-like receptor 9 agonist': 6, 'Neuronal acetylcholine receptor; alpha4/beta2 agonist': 5, 'Arachidonate 5-lipoxygenase inhibitor': 5, 'Beta-1 adrenergic receptor antagonist': 5, 'Dihydrofolate reductase inhibitor': 5, 'Melatonin receptor agonist': 5, 'Cytochrome P450 19A1 inhibitor': 5, 'Prostanoid IP receptor agonist': 5, 'Cyclin-dependent kinase 2 inhibitor': 5, 'Ghrelin receptor agonist': 5, 'Endothelin receptor, ET-A/ET-B antagonist': 5, 'Histone deacetylase inhibitor': 5, \"Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor\": 5, 'Synaptic vesicular amine transporter inhibitor': 5, 'Phosphodiesterase 5A inhibitor': 5, 'Peroxisome proliferator-activated receptor agonist': 5, 'Solute carrier family 22 member 12 inhibitor': 5, 'Xanthine dehydrogenase inhibitor': 5, 'Glycine receptor (alpha-1/beta) positive modulator': 5, 'Voltage-gated calcium channel modulator': 5, 'Dihydroorotate dehydrogenase inhibitor': 5, 'Corticotropin releasing factor receptor 1 antagonist': 5, 'Vasopressin V1a receptor antagonist': 5, 'Monoamine oxidase inhibitor': 5, 'Cell membrane inhibitor': 5, 'Estrogen receptor beta agonist': 5, 'Neuronal acetylcholine receptor; alpha4/beta2 partial agonist': 5, 'Ileal bile acid transporter inhibitor': 5, 'Oxytocin receptor antagonist': 5, 'Human immunodeficiency virus type 1 integrase inhibitor': 5, 'Serine/threonine-protein kinase Aurora-B inhibitor': 5, 'Bacterial DNA-directed RNA polymerase inhibitor': 5, 'Tyrosine-protein kinase JAK3 inhibitor': 5, 'Orexin receptor antagonist': 5, 'Neuronal acetylcholine receptor protein alpha-7 subunit partial agonist': 5, 'Prostanoid EP2 receptor agonist': 5, 'Voltage-gated N-type calcium channel alpha-1B subunit blocker': 5, 'C-C chemokine receptor type 5 antagonist': 5, 'Calcitonin receptor agonist': 5, 'Surfactant agent': 5, 'Luteinizing hormone/Choriogonadotropin receptor agonist': 5, 'Sclerostin inhibitor': 5, 'Beta-nerve growth factor inhibitor': 5, 'T-cell surface antigen CD4 inhibitor': 5, 'Fibronectin binding agent': 5, 'Cytotoxic T-lymphocyte protein 4 inhibitor': 5, 'Asparagine hydrolytic enzyme': 5, 'Fibroblast growth factor receptor 1 inhibitor': 5, 'Neurotrophic tyrosine kinase receptor inhibitor': 5, 'Cystic fibrosis transmembrane conductance regulator positive modulator': 5, 'Metabotropic glutamate receptor 5 modulator': 5, 'PI3-kinase p110-alpha subunit inhibitor': 5, 'Janus Kinase (JAK) inhibitor': 5, 'Cyclin-dependent kinase 4 inhibitor': 5, 'Microtubule-associated protein tau inhibitor': 5, 'Lymphocyte activation gene 3 protein inhibitor': 5, 'T-cell immunoreceptor with Ig and ITIM domains inhibitor': 5, 'Aldose reductase inhibitor': 4, 'Sodium-(potassium)-chloride cotransporter 2 inhibitor': 4, 'Retinoic acid receptor agonist': 4, 'DNA topoisomerase II inhibitor': 4, 'Cannabinoid CB1 receptor agonist': 4, 'Ribonucleoside-diphosphate reductase RR1 inhibitor': 4, 'Potassium-transporting ATPase inhibitor': 4, 'DNA polymerase/reverse transcriptase inhibitor': 4, 'Voltage-gated potassium channel blocker': 4, 'Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor': 4, '70S ribosome inhibitor': 4, 'Serotonin 3 (5-HT3) receptor antagonist': 4, 'Vasopressin V2 receptor antagonist': 4, 'Catechol O-methyltransferase inhibitor': 4, 'GABA-A receptor; anion channel agonist': 4, 'Serotonin 1a (5-HT1a) receptor antagonist': 4, 'Mu opioid receptor partial agonist': 4, 'Dopamine D2 receptor partial agonist': 4, '26S proteosome inhibitor': 4, 'Toll-like receptor 7 agonist': 4, 'Adrenergic receptor alpha antagonist': 4, 'Metabotropic glutamate receptor 2 agonist': 4, 'Kinesin-like protein 1 inhibitor': 4, 'Glucocorticoid receptor antagonist': 4, 'LXR-beta agonist': 4, 'Gamma-secretase inhibitor': 4, 'Cyclin-dependent kinase inhibitor': 4, 'Sunscreen': 4, 'Parathyroid hormone receptor agonist': 4, 'DNA topoisomerase II alpha inhibitor': 4, 'Sphingosine 1-phosphate receptor Edg-1 agonist': 4, 'Serotonin 6 (5-HT6) receptor antagonist': 4, 'Envelope glycoprotein inhibitor': 4, 'Melanocortin receptor 2 agonist': 4, 'Growth hormone receptor agonist': 4, 'Glucocerebroside hydrolytic enzyme': 4, 'Bile acids sequestering agent': 4, 'Myeloid cell surface antigen CD33 binding agent': 4, 'Hyaluronic acid hydrolytic enzyme': 4, 'Plasma kallikrein inhibitor': 4, 'RNA-directed RNA polymerase L inhibitor': 4, 'T cell surface glycoprotein CD3 cross-linking agent': 4, 'Epithelial cell adhesion molecule binding agent': 4, 'Tumor necrosis factor receptor superfamily member 5 inhibitor': 4, 'Lymphocyte differentiation antigen CD38 inhibitor': 4, 'Granulocyte-macrophage colony-stimulating factor inhibitor': 4, '11-beta-hydroxysteroid dehydrogenase 1 inhibitor': 4, 'P2X purinoceptor 7 antagonist': 4, 'Glucagon receptor antagonist': 4, 'Angiopoietin-2 inhibitor': 4, 'CD40 ligand inhibitor': 4, 'Mesothelin binding agent': 4, 'Receptor protein-tyrosine kinase erbB-2 binding agent': 4, 'Disialoganglioside GD2 binding agent': 4, 'Envelope polyprotein GP160 inhibitor': 4, 'Tumor necrosis factor receptor superfamily member 5 agonist': 4, 'Hexokinase type IV activator': 4, 'PI3-kinase p110-beta subunit inhibitor': 4, 'Beta-secretase 1 inhibitor': 4, 'Epidermal growth factor receptor inhibitor': 4, 'Serine-protein kinase ATR inhibitor': 4, 'Isocitrate dehydrogenase [NADP] cytoplasmic inhibitor': 4, 'Estrogen receptor alpha degrader': 4, 'Programmed cell death 1 ligand 1 binding agent': 4, 'T cell surface glycoprotein CD3 binding agent': 4, 'Carbonic anhydrase I inhibitor': 3, 'Bacterial dihydrofolate reductase inhibitor': 3, 'DNA gyrase inhibitor': 3, 'Adrenergic receptor alpha-2 agonist': 3, 'Retinoid receptor agonist': 3, 'CRL4(CRBN) E3 ubiquitin ligase inhibitor': 3, 'HERG blocker': 3, 'Neurokinin 3 receptor antagonist': 3, 'Ergosterol sequestering agent': 3, 'Tyrosinase inhibitor': 3, 'GABA receptor alpha-2 subunit positive allosteric modulator': 3, 'GABA-A receptor; anion channel positive modulator': 3, 'Glutamate NMDA receptor; GRIN1/GRIN2B antagonist': 3, 'Cysteinyl leukotriene receptor 1 antagonist': 3, 'Matrix metalloproteinase 9 inhibitor': 3, 'Cyclooxygenase-1 inhibitor': 3, 'Thromboxane A2 receptor antagonist': 3, 'Serotonin 1b (5-HT1b) receptor agonist': 3, 'GABA-B receptor agonist': 3, 'Dopamine transporter inhibitor': 3, 'Phosphodiesterase 3 inhibitor': 3, 'Plasminogen inhibitor': 3, 'Reverse transcriptase inhibitor': 3, 'Cholecystokinin B receptor antagonist': 3, 'Dopamine D2 receptor agonist': 3, 'Progesterone receptor antagonist': 3, 'Glycogen synthase kinase-3 beta inhibitor': 3, 'Interleukin-8 receptor B antagonist': 3, 'Vasopressin receptor agonist': 3, 'Prostanoid DP receptor antagonist': 3, 'PI3-kinase p110-gamma subunit inhibitor': 3, 'Oxytocin receptor agonist': 3, 'Bradykinin B1 receptor antagonist': 3, 'Thyroid peroxidase inhibitor': 3, 'Cytochrome P450 17A1 inhibitor': 3, 'Adenosine A2b receptor antagonist': 3, 'Integrin alpha-V/beta-3 antagonist': 3, 'Histamine H3 receptor inverse agonist': 3, 'Osmotic laxative': 3, 'PARP 1, 2 and 3 inhibitor': 3, 'Tubulin disrupting agent': 3, 'Fibroblast growth factor receptor 3 inhibitor': 3, 'Apoptosis regulator Bcl-2 inhibitor': 3, 'Thyroid hormone receptor beta-1 agonist': 3, 'Glycine transporter 1 inhibitor': 3, 'Neuropeptide Y receptor type 5 antagonist': 3, 'Dopamine D2 receptor modulator': 3, 'Kelch-like ECH-associated protein 1 inhibitor': 3, 'Melanocortin receptor 4 agonist': 3, 'Mineralocorticoid receptor agonist': 3, 'Synaptosomal-associated protein 25 inhibitor': 3, 'Secretin receptor agonist': 3, 'Uric acid oxidative enzyme': 3, 'Heparan sulfate hydrolytic enzyme': 3, 'Integrin alpha-4/beta-7 inhibitor': 3, 'Follicle stimulating hormone receptor agonist': 3, 'Polypeptides proteolytic enzyme': 3, 'Interleukin-1 beta inhibitor': 3, 'Thrombopoietin receptor agonist': 3, 'Interleukin-6 receptor alpha subunit inhibitor': 3, 'C-C chemokine receptor type 5 inhibitor': 3, 'Glycoprotein inhibitor': 3, 'Transforming growth factor beta-1 inhibitor': 3, 'Neural cell adhesion molecule 1 binding agent': 3, 'Lipopolysaccharide (LPS) inhibitor': 3, 'Blood group Rh(D) polypeptide inhibitor': 3, 'Histamine H4 receptor antagonist': 3, 'Serine/threonine-protein kinase PIM inhibitor': 3, 'Glucagon-like peptide 2 receptor agonist': 3, 'Platelet-derived growth factor receptor inhibitor': 3, 'Potassium chelating agent': 3, 'Epidermal growth factor receptor erbB1 antagonist': 3, 'Mucin-1 other': 3, 'Ganglioside GD3 other': 3, 'Interferon gamma inhibitor': 3, 'Carbonic anhydrase IX binding agent': 3, 'Tumor-associated antigen 72 binding agent': 3, 'Cell surface A33 antigen binding agent': 3, 'Integrin beta-2 inhibitor': 3, 'Interleukin-2 receptor alpha chain binding agent': 3, 'Disialoganglioside GD2 other': 3, 'Tumor necrosis factor receptor superfamily member 4 agonist': 3, 'C-C chemokine receptor type 1 antagonist': 3, 'Thioredoxin reductase 1 inhibitor': 3, 'Tumour suppressor p53/oncoprotein Mdm2 inhibitor': 3, 'Folate receptor alpha binding agent': 3, 'Glucocorticoid receptor modulator': 3, 'Poly [ADP-ribose] polymerase-1 inhibitor': 3, 'Hemagglutinin inhibitor': 3, 'SMN2 pre-mRNA positive modulator': 3, 'Toll-like receptor 8 agonist': 3, 'MAP kinase ERK1 inhibitor': 3, 'Cell division cycle 7-related protein kinase inhibitor': 3, 'Egl nine homolog 1 inhibitor': 3, 'Fibroblast growth factor receptor 2 inhibitor': 3, 'Transthyretin mRNA RNAi inhibitor': 3, 'Interleukin-3 receptor subunit alpha binding agent': 3, 'Tissue factor pathway inhibitor inhibitor': 3, 'Complement C3 inhibitor': 3, 'Tyrosine-protein kinase receptor RET inhibitor': 3, 'Mitogen-activated protein kinase; ERK1/ERK2 inhibitor': 3, 'Spike glycoprotein inhibitor': 3, 'LDL-associated phospholipase A2 inhibitor': 2, 'Dopamine transporter releasing agent': 2, 'Carbonic anhydrase inhibitor': 2, 'Serotonin 3a (5-HT3a) receptor antagonist': 2, 'Enoyl-[acyl-carrier-protein] reductase inhibitor': 2, 'Muscarinic acetylcholine receptor M1 antagonist': 2, 'Adrenergic receptor alpha-2 antagonist': 2, 'Bacterial enoyl-[acyl-carrier-protein] reductase inhibitor': 2, 'Beta-1 adrenergic receptor partial agonist': 2, 'HMG-CoA reductase inhibitor': 2, 'Thromboxane-A synthase inhibitor': 2, 'Histone deacetylase 1 inhibitor': 2, 'Thyroid hormone receptor agonist': 2, 'Amiloride-sensitive sodium channel, ENaC blocker': 2, 'Monoamine oxidase A inhibitor': 2, 'Vanilloid receptor agonist': 2, 'Opioid receptors; mu/kappa/delta antagonist': 2, 'Nischarin agonist': 2, 'Adrenergic receptor agonist': 2, 'Sodium channel protein type V alpha subunit blocker': 2, 'Tyrosine-protein kinase SRC inhibitor': 2, 'VP1 capsid protein disrupting agent': 2, 'Adenosine deaminase inhibitor': 2, 'Ferriprotoporphyrin IX inhibitor': 2, 'Protein farnesyltransferase inhibitor': 2, 'Squalene monooxygenase inhibitor': 2, 'Glutamate [NMDA] receptor blocker': 2, 'Acyl coenzyme A:cholesterol acyltransferase 1 inhibitor': 2, 'Adenosine A3 receptor agonist': 2, 'Protein kinase C beta inhibitor': 2, 'Farnesyl diphosphate synthase inhibitor': 2, '1,3-beta-glucan synthase inhibitor': 2, 'Lanosterol 14-alpha demethylase inhibitor': 2, 'Monoamine oxidase B inhibitor': 2, \"Inosine-5'-monophosphate dehydrogenase 1 inhibitor\": 2, 'Histamine H1 receptor inverse agonist': 2, 'Dopamine D3 receptor agonist': 2, 'Neurokinin 2 receptor antagonist': 2, 'Retinoid X receptor agonist': 2, 'Ceramide glucosyltransferase inhibitor': 2, 'Dopamine D3 receptor antagonist': 2, 'Leukotriene B4 receptor 1 antagonist': 2, '5-lipoxygenase activating protein inhibitor': 2, 'Platelet activating factor receptor antagonist': 2, 'HIV-1 protease inhibitor': 2, 'Nitric oxide synthase, inducible inhibitor': 2, 'Integrin alpha-IIb/beta-3 inhibitor': 2, '80S Ribosome inhibitor': 2, 'Calcium-activated potassium channel subunit alpha-1 activator': 2, 'Phospholipase A2 group IIA inhibitor': 2, 'Synaptic vesicle glycoprotein 2A modulator': 2, 'P-glycoprotein 1 inhibitor': 2, 'Dihydropyrimidine dehydrogenase inhibitor': 2, 'Interleukin-8 receptor A modulator': 2, 'Cannabinoid CB1 receptor negative allosteric modulator': 2, 'Cathepsin K inhibitor': 2, 'Iron chelating agent': 2, 'Epoxide hydratase inhibitor': 2, 'Carbonic anhydrase II inhibitor': 2, 'Neuraminidase inhibitor': 2, 'DNA-directed RNA polymerase inhibitor': 2, 'Thyrotropin-releasing hormone receptor agonist': 2, 'DNA (cytosine-5)-methyltransferase 3A inhibitor': 2, '80S Ribosome modulator': 2, 'Neuronal acetylcholine receptor protein alpha-7 subunit positive allosteric modulator': 2, 'Dihydropteroate synthetase inhibitor': 2, 'Motilin receptor agonist': 2, 'Neuronal acetylcholine receptor; alpha4/beta2 antagonist': 2, 'Alpha glucosidase inhibitor': 2, 'Osmotic agent': 2, 'Iron sequestering agent': 2, 'Nutritional support': 2, 'Serotonin 2a (5-HT2a) receptor inverse agonist': 2, 'Kappa opioid receptor agonist': 2, 'Glutamine sequestering agent': 2, 'Diagnostic': 2, 'Fatty acids hydrolytic enzyme': 2, 'Starch hydrolytic enzyme': 2, \"2'-deoxyadenosine hydrolytic enzyme\": 2, 'Atrial natriuretic peptide receptor A agonist': 2, 'Interleukin-2 receptor inhibitor': 2, 'T-cell surface antigen CD2 inhibitor': 2, 'Major intermediate early region 2 mRNA antisense inhibitor': 2, 'DNA hydrolytic enzyme': 2, 'Thyroid stimulating hormone receptor agonist': 2, 'Interleukin-1 receptor antagonist': 2, 'T cell surface glycoprotein CD3 inhibitor': 2, 'Insulin-like growth factor I receptor agonist': 2, 'Fibroblast growth factor receptor 2 agonist': 2, 'Dermatan sulfate hydrolytic enzyme': 2, 'T-lymphocyte activation antigen CD86 inhibitor': 2, 'Interleukin-12 inhibitor': 2, 'Cyclophilin A inhibitor': 2, 'Orexin receptor 1 antagonist': 2, 'c-Jun N-terminal kinase 1 inhibitor': 2, 'Anandamide amidohydrolase inhibitor': 2, 'Enoyl-[acyl-carrier-protein] reductase [NADPH] inhibitor': 2, 'Alcohol dehydrogenase class III inhibitor': 2, 'Mucin-16 other': 2, 'Reticulon-4 inhibitor': 2, 'Beta amyloid A4 protein inhibitor': 2, 'Hepatocyte growth factor inhibitor': 2, 'Transmembrane glycoprotein NMB binding agent': 2, 'Trophoblast glycoprotein other': 2, 'Interferon alpha inhibitor': 2, 'Inhibin beta A chain inhibitor': 2, 'Tenascin other': 2, 'Tumor necrosis factor receptor superfamily member 9 agonist': 2, 'Cardiac myosin activator': 2, 'Kappa opioid receptor antagonist': 2, 'Tyrosine-protein kinase TIE-2 inhibitor': 2, 'Serotonin 4 (5-HT4) receptor partial agonist': 2, 'GABA-A receptor; anion channel partial agonist': 2, 'Purinergic receptor P2Y12 antagonist': 2, 'Transthyretin stabiliser': 2, 'Tryptophan 5-hydroxylase inhibitor': 2, 'Heat-stable enterotoxin receptor agonist': 2, 'Dual specificity mitogen-activated protein kinase kinase; MEK1/2 inhibitor': 2, 'Somatostatin receptor 2 agonist': 2, 'Sulfonylurea receptors; K-ATP channels opener': 2, 'Retinoic acid receptor gamma agonist': 2, 'Microsomal triglyceride transfer protein inhibitor': 2, 'Macrophage migration inhibitory factor inhibitor': 2, 'Soluble guanylate cyclase positive allosteric modulator': 2, 'TRAIL receptor-1 agonist': 2, 'Telomerase reverse transcriptase inhibitor': 2, 'Interleukin-5 inhibitor': 2, 'Leukocyte elastase inhibitor': 2, 'Interleukin-18 inhibitor': 2, 'Integrin alpha-5/beta-1 antagonist': 2, 'Interleukin-4 inhibitor': 2, 'p53 mRNA antisense inhibitor': 2, \"Protein kinase C alpha mRNA 3'UTR  antisense inhibitor\": 2, 'Triglyceride hydrolytic enzyme': 2, 'Clusterin mRNA antisense inhibitor': 2, 'E2F inhibitor': 2, 'Bcl-2 mRNA antisense inhibitor': 2, \"Intercellular adhesion molecule-1 mRNA 3'UTR antisense inhibitor\": 2, 'Hepatocyte growth factor receptor agonist': 2, 'von Willebrand factor inhibitor': 2, 'Intercellular adhesion molecule-1 antagonist': 2, 'CD22 inhibitor': 2, 'CD44 antigen binding agent': 2, 'T-cell receptor inhibitor': 2, 'T-cell surface antigen CD4 negative modulator': 2, 'D-lactose hydrolytic enzyme': 2, 'Angiopoietin-1 inhibitor': 2, 'Protective antigen binding agent': 2, 'Toxin A binding agent': 2, 'Epithelial cell adhesion molecule other': 2, 'Toxin A inhibitor': 2, 'CD70 antigen binding agent': 2, 'Mucin-5AC binding agent': 2, 'Tumor necrosis factor ligand superfamily member 4 inhibitor': 2, 'T-cell surface glycoprotein CD5 binding agent': 2, 'T-cell surface glycoprotein CD3 epsilon chain inhibitor': 2, 'Fibroblast activation protein alpha binding agent': 2, 'Globotriosylceramide hydrolytic enzyme': 2, 'Bulk-forming laxative': 2, 'Mucin-16 binding agent': 2, 'Coagulation factor VIII inhibitor': 2, 'Probiotic': 2, 'Myeloid cell surface antigen CD33 other': 2, 'Leukocyte antigen CD37 binding agent': 2, 'Light chain aggregates inhibitor': 2, 'Protective antigen inhibitor': 2, 'Interleukin-2 receptor beta chain inhibitor': 2, 'Insulin-like growth factor I inhibitor': 2, 'C-X-C motif chemokine 10 inhibitor': 2, 'Dickkopf-related protein 1 inhibitor': 2, 'Delta-like protein 4 inhibitor': 2, 'DNA-histone H1 complex binding agent': 2, 'Complement factor D inhibitor': 2, 'Disialoganglioside GD2 inhibitor': 2, 'Tumor necrosis factor receptor superfamily member 18 agonist': 2, 'Envelope glycoprotein gp160 inhibitor': 2, 'Leukocyte common antigen binding agent': 2, 'P-selectin antagonist': 2, 'Macrophage colony-stimulating factor 1 inhibitor': 2, 'Low calcium response locus protein V inhibitor': 2, 'Platelet-derived growth factor receptor beta inhibitor': 2, 'Myelin-associated glycoprotein inhibitor': 2, 'Tenascin binding agent': 2, 'Thymic stromal lymphopoietin inhibitor': 2, 'Tumor necrosis factor ligand superfamily member 12 inhibitor': 2, 'Interleukin-8 inhibitor': 2, 'Interleukin-1 alpha inhibitor': 2, 'Gonadotropin-releasing hormone receptor agonist': 2, 'C-C chemokine receptor type 9 antagonist': 2, 'Phosphodiesterase 9A inhibitor': 2, 'Bcr/Abl fusion protein inhibitor': 2, 'Hypoxia-inducible factor prolyl hydroxylase inhibitor': 2, 'Nociceptin receptor agonist': 2, 'TGF-beta receptor type I inhibitor': 2, 'Prostanoid EP4 receptor antagonist': 2, 'Hepatitis C virus NS5B RNA-dependent RNA polymerase negative allosteric modulator': 2, 'Sodium/glucose cotransporter 1 inhibitor': 2, 'Heat shock protein beta-1 (HSP27) mRNA antisense inhibitor': 2, 'Metabotropic glutamate receptor 5 antagonist': 2, 'Neprilysin inhibitor': 2, 'L-arginine hydrolytic enzyme': 2, 'Glucose-dependent insulinotropic receptor agonist': 2, 'Adenosine A1 receptor partial agonist': 2, 'Programmed cell death 1 ligand 1 inhibitor': 2, 'Nociceptin receptor antagonist': 2, 'RAF serine/threonine protein kinase inhibitor': 2, 'Acetyl-CoA carboxylase inhibitor': 2, 'Glutamate [NMDA] receptor partial agonist': 2, 'Dual specificity protein kinase TTK inhibitor': 2, 'Ephrin type-B receptor 4 inhibitor': 2, 'Metabotropic glutamate receptor 5 negative allosteric modulator': 2, 'Calcium sensing receptor positive allosteric modulator': 2, 'Mitochondrial complex I (NADH dehydrogenase) inhibitor': 2, 'Nerve growth factor receptor Trk-A inhibitor': 2, 'Tyrosine-protein kinase receptor UFO inhibitor': 2, 'Tumor-associated calcium signal transducer 2 binding agent': 2, 'Indoleamine 2,3-dioxygenase inhibitor': 2, 'Epidermal growth factor receptor erbB1 binding agent': 2, 'Glucagon receptor inhibitor': 2, 'Transient receptor potential cation channel subfamily A member 1 antagonist': 2, 'Calcitonin gene-related peptide inhibitor': 2, 'Wilms tumor protein vaccine antigen': 2, 'microRNA-155 inhibitor': 2, 'Muscarinic acetylcholine receptor M1 positive allosteric modulator': 2, 'Polymerase acidic protein inhibitor': 2, \"STAT-3 mRNA 3'UTR antisense inhibitor\": 2, 'microRNA 21 antisense inhibitor': 2, 'c-Jun N-terminal kinase 3 inhibitor': 2, 'Galectin-3 inhibitor': 2, 'Tyrosine-protein kinase TYK2 inhibitor': 2, 'Methionine aminopeptidase 2 inhibitor': 2, 'IgG receptor FcRn large subunit p51 antagonist': 2, 'ErbB-2/ErbB-3 heterodimer inhibitor': 2, 'p53 mRNA RNAi inhibitor': 2, 'FGF1/KLB agonist': 2, '1-phosphatidylinositol 3-phosphate 5-kinase inhibitor': 2, '5-aminolevulinate synthase mRNA RNAi inhibitor': 2, 'Hydroxyacid oxidase 1 mRNA RNAi inhibitor': 2, 'T-cell immunoreceptor with Ig and ITIM domains antagonist': 2, 'IgG receptor FcRn large subunit p51 inhibitor': 2, 'IL36 receptor antagonist': 2, 'Inducible T-cell costimulator agonist': 2, 'Hepatitis A virus cellular receptor 2 inhibitor': 2, 'Angiopoietin like 3 (ANGPTL3) mRNA antisense inhibitor': 2, 'Tumor necrosis factor receptor superfamily member 17 binding agent': 2, 'CD40 ligand antagonist': 2, 'GTPase KRas inhibitor': 2, 'Tumor necrosis factor receptor superfamily member 4 antagonist': 2, 'Interleukin-33 inhibitor': 2, 'GABA-A receptor; anion channel allosteric antagonist': 1, 'Carbonic anhydrase VII inhibitor': 1, 'Beta-1 adrenergic receptor inhibitor': 1, 'Radioprotective agent': 1, 'Calcium-activated potassium channel subunit alpha-1 opener': 1, 'Tyrosine-protein kinase Lyn positive allosteric modulator': 1, 'Adenosine receptor agonist': 1, 'Prostanoid EP1 receptor agonist': 1, 'Zinc chelating agent': 1, 'Glutathione reductase inhibitor': 1, 'Bacterial penicillin-binding protein 2 inhibitor': 1, 'Prostaglandin E2 receptor agonist': 1, 'Muscarinic acetylcholine receptor M3 agonist': 1, 'Succinate semialdehyde dehydrogenase inhibitor': 1, 'Adenosine receptor antagonist': 1, 'GABA-A receptor negative allosteric modulator': 1, 'C-X-C chemokine receptor type 4 partial agonist': 1, 'Glutathione precursor': 1, 'Hemoglobin HbA negative modulator': 1, 'Prostanoid EP3 receptor agonist': 1, 'ATP-binding cassette sub-family A member 1 inhibitor': 1, 'Fatty acid synthase inhibitor': 1, 'Tubulin beta inhibitor': 1, 'RNA inhibitor': 1, 'Muscarinic acetylcholine receptor M4 agonist': 1, 'Adenosine A2 receptor antagonist': 1, 'Cholinesterases; ACHE & BCHE inhibitor': 1, 'Alpha-ketoglutarate-dependent dioxygenase FTO inhibitor': 1, 'RAS inhibitor': 1, 'Serum amyloid P-component cross-linking agent': 1, 'Alpha-1a adrenergic receptor antagonist': 1, 'Retinoic acid receptor beta agonist': 1, 'Steroid 5-alpha-reductase 2 inhibitor': 1, 'Vitamin K-dependent gamma-carboxylase inhibitor': 1, 'Isoleucyl-tRNA synthetase inhibitor': 1, 'Beta-2 adrenergic receptor partial agonist': 1, 'Adrenergic receptor beta antagonist': 1, 'Steryl-sulfatase inhibitor': 1, 'Bacterial urease inhibitor': 1, 'Sodium channel protein type II alpha subunit blocker': 1, 'Renal dipeptidase inhibitor': 1, 'D-alanylalanine synthetase inhibitor': 1, 'Phosphodiesterase 3A inhibitor': 1, 'Angiotensin II type 2 (AT-2) receptor antagonist': 1, 'Sulfonylurea receptor 2, Kir6.2 opener': 1, 'Mitogen-activated protein kinase kinase kinase 11 inhibitor': 1, 'Melanocortin receptor 1 agonist': 1, 'KCNQ (Kv7) potassium channel opener': 1, 'Protein synthesis inhibitor': 1, 'Peptidoglycan inhibitor': 1, 'Cyclophilin A modulator': 1, 'Antioxidant': 1, 'Colonic bacteria substrate': 1, 'Leukotriene B4 receptor antagonist': 1, 'Solute carrier family 22 member 6 inhibitor': 1, 'Retinoid X receptor alpha antagonist': 1, 'Translocator protein partial agonist': 1, 'Equilibrative nucleoside transporter 1 inhibitor': 1, 'Dopamine D1 receptor antagonist': 1, 'Vanilloid receptor opener': 1, 'Glutamate receptor ionotropic, AMPA 2 antagonist': 1, 'Estrogen receptor alpha modulator': 1, 'Aldehyde dehydrogenase inhibitor': 1, 'Prostanoid EP4 receptor agonist': 1, 'Voltage-activated calcium channel beta 1 subunit blocker': 1, 'Serotonin 2 (5-HT2) receptor antagonist': 1, 'DNA polymerase catalytic subunit inhibitor': 1, 'Reactive metabolite scavenging agent': 1, 'Pyruvate dehydrogenase kinase inhibitor': 1, 'Dihydropteroate synthase 1 inhibitor': 1, 'GABA-A receptor; agonist GABA site agonist': 1, 'Saline laxative': 1, 'Antioxidant, anti-inflammatory, antiplatelet': 1, 'Gamma-amino-N-butyrate transaminase inhibitor': 1, 'Sodium channel protein type IV alpha subunit blocker': 1, 'Cholecystokinin receptor antagonist': 1, 'Betaine-homocysteine S-methyltransferase substrate': 1, 'Retinoic acid receptor alpha agonist': 1, 'Niemann-Pick C1-like protein 1 inhibitor': 1, 'Dopamine D1 and D2 receptor antagonist': 1, 'Alpha-galactosidase A stabiliser': 1, 'Thymidylate synthase antagonist': 1, 'GABA-B receptor antagonist': 1, 'Plasminogen activator inhibitor-1 inhibitor': 1, 'Nicotinic acetylcholine receptor alpha4/beta2/alpha5 partial agonist': 1, 'Transient receptor potential cation channel subfamily V member 4 inhibitor': 1, 'Arachidonate 12-lipoxygenase inhibitor': 1, 'GABA-A receptor; agonist GABA site positive allosteric modulator': 1, 'Squalene synthetase inhibitor': 1, 'Alpha-1d adrenergic receptor antagonist': 1, 'Serotonin 4 (5-HT4) receptor antagonist': 1, 'Retinoid receptor modulator': 1, 'Beta amyloid A4 protein stabiliser': 1, 'DNA polymerase (alpha/delta/epsilon) inhibitor': 1, 'GABA receptor beta-3 subunit positive allosteric modulator': 1, 'Prostaglandin-H2 D-isomerase inhibitor': 1, 'D2-like dopamine receptor agonist': 1, 'Alcohol dehydrogenase class I inhibitor': 1, 'Reducing agent': 1, 'Acetylcholinesterase 1 inhibitor': 1, '4-hydroxyphenylpyruvate dioxygenase inhibitor': 1, 'Glycine receptor (alpha-1/beta) agonist': 1, 'Gastric lipase inhibitor': 1, 'Estrogen receptor antagonist': 1, 'Intermediate conductance calcium-activated potassium channel protein 4 opener': 1, 'Adrenergic receptor alpha-1 antagonist': 1, 'Delta(24)-sterol reductase inhibitor': 1, 'Glutathione reductase ': 1, 'Gamma-secretase modulator': 1, 'CDK6/cyclin D1 inhibitor': 1, '20S proteosome inhibitor': 1, 'Caspase inhibitor': 1, 'Pyruvate:ferredoxin oxidoreductase inhibitor': 1, 'DNA polymerase inhibitor': 1, '1-deoxy-D-xylulose 5-phosphate reductoisomerase, apicoplastic inhibitor': 1, 'Photosensitizer': 1, 'Leucine-tRNA ligase inhibitor': 1, 'Potassium channel, inwardly rectifying, subfamily J, member 11 opener': 1, 'Cannabinoid CB1 receptor inverse agonist': 1, 'Mycobacterium tuberculosis H37Rv inhibitor': 1, 'Serotonin 1a (5-HT1a) receptor partial agonist': 1, 'Copper chelating agent': 1, 'Nucleoprotein inhibitor': 1, 'Elongation factor G inhibitor': 1, 'RNA-directed RNA polymerase inhibitor': 1, 'Toll-like receptor 4 inhibitor': 1, 'Cytochrome b inhibitor': 1, 'Ribonucleotide reductase inhibitor': 1, 'Serotonin (5-HT) receptor antagonist': 1, 'Glutamate [NMDA] receptor negative allosteric modulator': 1, 'Calmodulin inhibitor': 1, 'DNA binding agent': 1, 'Purinergic receptor P2Y12 negative allosteric modulator': 1, 'Voltage-gated calcium channel blocker': 1, 'Antioxidant and mitochondrial electron carrier': 1, 'GABA A receptor alpha-1/beta-1/gamma-2 positive allosteric modulator': 1, 'Voltage-sensitive sodium channel blocker': 1, 'Nitric oxide synthase inhibitor': 1, 'Transient receptor potential cation channel subfamily M member 8 opener': 1, 'Alpha-1a adrenergic receptor partial agonist': 1, 'Thioredoxin inhibitor': 1, 'Aryl hydrocarbon receptor agonist': 1, 'Amidophosphoribosyltransferase inhibitor': 1, 'GABA receptor alpha-1 subunit positive allosteric modulator': 1, 'SRC inhibitor': 1, 'Intermediate conductance calcium-activated potassium channel protein 4 blocker': 1, 'Maltase-glucoamylase inhibitor': 1, 'Antimicrobial preservative, used in vaccines': 1, 'Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 blocker': 1, 'Pancreatic alpha-amylase inhibitor': 1, 'Norepinephrine transporter releasing agent': 1, \"Uridine 5'-monophosphate synthase inhibitor\": 1, '11-beta-hydroxysteroid dehydrogenase inhibitor': 1, 'Heavy metals chelating agent': 1, 'Neurotensin receptor 1 antagonist': 1, 'Smoothened homolog inhibitor': 1, 'GABA-B receptor 1 agonist': 1, 'Cytochrome P450 26A1 inhibitor': 1, 'Elongation factor 1-alpha 2 inhibitor': 1, 'Protein P inhibitor': 1, 'Translocator protein agonist': 1, 'Enoyl-[acyl-carrier-protein] reductase (FabI) inhibitor': 1, 'Cytochrome P450 11A1 inhibitor': 1, 'Transmembrane glycoprotein gp41 inhibitor': 1, 'Serine/threonine-protein kinase BGLF4 inhibitor': 1, 'Cholecystokinin A receptor antagonist': 1, 'DNA-directed RNA polymerase I subunit RPA1 inhibitor': 1, 'Vasopressin V1b receptor antagonist': 1, 'Liver X receptor agonist': 1, 'Nicotinamide phosphoribosyltransferase inhibitor': 1, 'Cholesterol sequestering agent': 1, 'DNA-(apurinic or apyrimidinic site) lyase inhibitor': 1, 'Urotensin II receptor antagonist': 1, 'Protein kinase C (PKC) inhibitor': 1, 'D2-like dopamine receptor antagonist': 1, 'Prolow-density lipoprotein receptor-related protein 1 binding agent': 1, 'Poly [ADP-ribose] polymerase 2 inhibitor': 1, 'DOPA decarboxylase inhibitor': 1, 'P-type ATPase inhibitor': 1, 'Reactive nitro radical': 1, 'Calcium sensing receptor antagonist': 1, 'Antiseptic': 1, 'Releases active oxygen': 1, 'C55-isoprenyl pyrophosphate inhibitor': 1, 'pH lowering agent': 1, 'Glutamate-gated chloride channel modulator': 1, 'Neutralises acid': 1, 'Lung surfactant': 1, 'Estrogen receptor beta modulator': 1, 'Inositol-1(or 4)-monophosphatase 1 inhibitor': 1, 'Tyrosine 3-hydroxylase inhibitor': 1, '3-beta-hydroxysteroid dehydrogenase/delta 5-->4-isomerase type II inhibitor': 1, 'Steroid 5-alpha-reductase inhibitor': 1, 'Lead chelating agent': 1, 'Penicillin-binding protein inhibitor': 1, 'Cytochrome P450 inhibitor': 1, 'Chloride channel protein 2 opener': 1, 'Elongation factor 2 inhibitor': 1, 'Platelet-derived growth factor receptor agonist': 1, 'Vesicle-associated membrane protein 2 inhibitor': 1, 'Interferon gamma receptor agonist': 1, 'Bilirubin sequestering agent': 1, 'Vasopressin V2 receptor agonist': 1, 'Vascular endothelial growth factor A antagonist': 1, 'Calcium sequestering agent': 1, 'Interleukin-2 receptor agonist': 1, 'Growth hormone receptor antagonist': 1, 'Integrin alpha-L/beta-2 (LFA-1) inhibitor': 1, 'Growth hormone-releasing hormone receptor agonist': 1, 'Fibrinogen inhibitor': 1, 'Iodine storage agent': 1, 'Interleukin 11 receptor alpha agonist': 1, 'Heparin inhibitor': 1, 'Granulocyte-macrophage colony-stimulating factor receptor agonist': 1, 'CAMPATH-1 antigen inhibitor': 1, 'Polypeptides hydrolytic enzyme': 1, 'Sucrose hydrolytic enzyme': 1, 'Skin preparation/antiseptic, oxidising agent': 1, 'Carbamoyl-phosphate synthase [ammonia], mitochondrial positive allosteric modulator': 1, 'G1/S-specific cyclin D1 inhibitor': 1, 'Hemagglutinin negative modulator': 1, 'Selectin inhibitor': 1, 'Casein kinase II alpha inhibitor': 1, 'NEDD8 activating enzyme inhibitor': 1, 'Diagnostic (when bound to a chelating agent)': 1, 'Tumor necrosis factor ligand superfamily member 11 inhibitor': 1, 'Prostatic acid phosphatase binding agent': 1, 'DNA terminase inhibitor': 1, 'Glutamate [NMDA] receptor positive allosteric modulator': 1, 'Envelope phospholipase F13 (p37) inhibitor': 1, 'Cholecystokinin A receptor agonist': 1, 'Slowly adapting pulmonary stretch receptor inhibitor': 1, 'Surfactant laxative': 1, 'Coagulation factor XII activator': 1, 'Cytotoxic': 1, '3-phosphoinositide dependent protein kinase-1 inhibitor': 1, 'Voltage-gated T-type calcium channel modulator': 1, 'Expectorant': 1, 'Lubricant': 1, 'Retinoid X receptor alpha modulator': 1, 'Vascular endothelial growth factor receptor 2 antagonist': 1, 'Mesothelin inhibitor': 1, 'Heterotrimeric lymphotoxin LTa1b2 inhibitor': 1, 'Phosphatidylserine inhibitor': 1, 'Interleukin-5 receptor subunit alpha inhibitor': 1, 'Interleukin-17 receptor A antagonist': 1, 'C-C motif chemokine 2 inhibitor': 1, 'Heat shock protein 90 homolog inhibitor': 1, 'SLAM family member 7 inhibitor': 1, 'Tumor necrosis factor receptor superfamily member 12A agonist': 1, 'Interleukin-9 inhibitor': 1, 'Mucin-5AC other': 1, 'Integrin beta-7 antagonist': 1, 'Folate receptor alpha inhibitor': 1, 'Interleukin-22 inhibitor': 1, 'Interleukin-1 beta negative allosteric modulator': 1, 'Carbonic anhydrase IX other': 1, 'Vascular endothelial growth factor receptor 1 antagonist': 1, 'Syndecan-1 binding agent': 1, 'T-cell differentiation antigen CD6 inhibitor': 1, 'Tumor necrosis factor receptor superfamily member 5 antagonist': 1, 'Granulocyte-macrophage colony-stimulating factor receptor antagonist': 1, 'HLA-DR antigens-associated invariant chain antagonist': 1, 'C-C chemokine receptor type 4 cross-linking agent': 1, 'Macrophage-stimulating protein receptor inhibitor': 1, 'Platelet-derived growth factor receptor alpha antagonist': 1, 'Hepatocyte growth factor receptor antagonist': 1, 'T-cell surface glycoprotein CD3 epsilon chain binding agent': 1, 'TNF-beta inhibitor': 1, 'Ganglioside GM3 (NeuGcGM3) inhibitor': 1, 'OX-2 membrane glycoprotein inhibitor': 1, 'Integrin alpha-IIb/beta-3 antagonist': 1, 'T-cell surface glycoprotein CD3 epsilon chain other': 1, 'T-cell surface antigen CD4 agonist': 1, 'Integrin alpha-2 antagonist': 1, 'Neuropilin-1 inhibitor': 1, 'Peroxisome proliferator-activated receptor gamma antagonist': 1, 'Quinone reductase 1) modulator': 1, 'Vasopressin V1a receptor agonist': 1, 'Free fatty acid receptor 1 positive allosteric modulator': 1, 'Methotrexate hydrolytic enzyme': 1, 'Alcohol dehydrogenase inhibitor': 1, 'Glycogen synthase kinase-3 inhibitor': 1, 'Serine/threonine-protein kinase WEE1 inhibitor': 1, 'Rho-associated protein kinase 2 inhibitor': 1, 'Hydroxycarboxylic acid receptor 2 agonist': 1, 'Integrin alpha-L/beta-2 (LFA-1) antagonist': 1, 'VP1 capsid protein inhibitor': 1, 'Cytochrome P450 3A inhibitor': 1, 'Fibronectin proteolytic enzyme': 1, 'Radioactive metals chelating agent': 1, 'Voltage-sensitive sodium channel alpha-subunit blocker': 1, 'Chloride channel protein 2 activator': 1, 'Pancreatic lipase inhibitor': 1, 'Dopamine receptors; D2 & D3 partial agonist': 1, 'Aminopeptidase inhibitor': 1, 'Proteinase-activated receptor 1 antagonist': 1, 'Cystic fibrosis transmembrane conductance regulator stabiliser': 1, 'Peroxisome proliferator-activated receptor gamma partial agonist': 1, 'Atrial natriuretic peptide receptor agonist': 1, 'Integrin alpha-4/beta-1 antagonist': 1, 'Cytosolic phospholipase A2 inhibitor': 1, 'Diamine oxidase activator': 1, 'Butyrylcholinesterase inhibitor': 1, 'Calcitonin gene-related peptide type 1 receptor agonist': 1, 'Caspase-8 inhibitor': 1, 'Dual specificity mitogen-activated protein kinase kinase 2 inhibitor': 1, 'DNA topoisomerase I stabiliser': 1, 'Bradykinin B2 receptor agonist': 1, 'Mineral supplement': 1, 'GABA-A receptor; anion channel antagonist': 1, 'Bradykinin B2 receptor antagonist': 1, 'Glycosaminoglycans modulator': 1, 'GABA-A receptor; anion channel inverse agonist': 1, 'Caspase-1 inhibitor': 1, 'Retinoid isomerohydrolase inhibitor': 1, 'Leptin receptor agonist': 1, 'Toll-like receptor 3 agonist': 1, 'Epidermal growth factor receptor erbB1 vaccine antigen': 1, 'Coagulation factor IX inhibitor': 1, 'Protein kinase C delta inhibitor': 1, 'Chondroitin-6-sulfate hydrolytic enzyme': 1, 'Envelope glycoprotein B inhibitor': 1, 'Lipopolysaccharide (LPS) sequestering agent': 1, 'Epithelial cell adhesion molecule inhibitor': 1, 'Receptor protein-tyrosine kinase erbB-2 cross-linking agent': 1, 'Complement receptor type 1 inhibitor': 1, 'Lipoteichoic acid inhibitor': 1, 'Vimentin other': 1, 'Clumping factor A inhibitor': 1, 'Shiga toxin subunit B inhibitor': 1, 'Beta amyloid A4 protein vaccine antigen': 1, 'T-cell surface antigen CD4 other': 1, 'Tumor necrosis factor receptor superfamily member 5 partial agonist': 1, 'Trophoblast glycoprotein cross-linking agent': 1, 'Major surface antigen inhibitor': 1, 'Amine oxidase, copper containing inhibitor': 1, 'Cystic fibrosis transmembrane conductance regulator inhibitor': 1, 'Globotriosylceramide': 1, 'CD22 other': 1, 'Human leukocyte antigen DR beta chain inhibitor': 1, 'Blood group Rh(D) polypeptide other': 1, 'Laxative': 1, 'Prostate specific antigen binding agent': 1, 'Insulin receptor substrate 1 mRNA antisense inhibitor': 1, 'Pyrophosphate hydrolytic enzyme': 1, 'Transforming growth factor beta-2 mRNA antisense inhibitor': 1, 'Relaxin receptor 1 activator': 1, 'microRNA 122 antisense inhibitor': 1, 'Interleukin-2 receptor alpha chain antagonist': 1, 'Lipopolysaccharide (LPS) other': 1, 'GDNF family receptor alpha-1 agonist': 1, 'Emollient/skin protectant': 1, 'Interferon alpha-1/13 binding agent': 1, 'tRNA hydrolytic enzyme': 1, 'Carcinoembryonic antigen-related cell adhesion molecule 5 other': 1, 'Vascular endothelial growth factor receptor 1 and 2 (Flt-1 and KDR) agonist': 1, 'Leukocyte adhesion molecule-1 inhibitor': 1, 'Interleukin 13 receptor binding agent': 1, 'Cellular tumor antigen p53 positive modulator': 1, 'Tumor necrosis factor receptor superfamily member 8 other': 1, 'Alpha-fetoprotein binding agent': 1, 'Toxin B inhibitor': 1, 'Interleukin-4 receptor subunit alpha antagonist': 1, 'Keratan sulfate hydrolytic enzyme': 1, 'Toll-like receptor 5 agonist': 1, 'Collagen hydrolytic enzyme': 1, 'HLA class II histocompatibility antigen, DRB1-15 beta chain modulator': 1, 'Antithrombin-III inhibitor': 1, 'Interferon lambda receptor agonist': 1, 'Melanoma cells disrupting agent': 1, 'Interleukin-6 receptor alpha subunit antagonist': 1, '5,6-dihydroxyindole-2-carboxylic acid oxidase other': 1, 'Anti-gas, surfactant': 1, 'Bulk forming laxative': 1, 'Basigin inhibitor': 1, 'Proteolytic enzyme': 1, 'Envelope glycoprotein H inhibitor': 1, 'Fibrinogen hydrolytic enzyme': 1, 'Epithelial cell adhesion molecule cross-linking agent': 1, 'Transforming growth factor beta-2 inhibitor': 1, 'Fibrinogen positive modulator': 1, 'Intercellular adhesion molecule-1 inhibitor': 1, 'Integrin beta-2 negative modulator': 1, 'Eotaxin inhibitor': 1, 'Immunoglobulin epsilon Fc receptor antagonist': 1, 'Leukocyte adhesion glycoprotein LFA-1 alpha inhibitor': 1, 'T-lymphocyte activation antigen CD80 inhibitor': 1, 'Basigin other': 1, 'Integrin alpha-M/beta-2 antagonist': 1, 'ICOS ligand inhibitor': 1, 'T-cell-specific surface glycoprotein CD28 agonist': 1, 'Tumor necrosis factor receptor superfamily member 8 binding agent': 1, 'Tumor necrosis factor receptor superfamily member 8 agonist': 1, 'High affinity immunoglobulin gamma Fc receptor I cross-linking agent': 1, 'Endothelin receptor ET-B binding agent': 1, 'Fibrinogen beta chain binding agent': 1, 'Serine/threonine-protein kinase receptor R3 inhibitor': 1, 'Programmed cell death 1 ligand 2 cross-linking agent': 1, 'CD276 antigen binding agent': 1, 'Botulinum neurotoxin type A inhibitor': 1, 'Endoglin inhibitor': 1, 'Interleukin-3 receptor subunit alpha inhibitor': 1, 'Monocyte differentiation antigen CD14 inhibitor': 1, 'B-lymphocyte antigen CD20 cross-linking agent': 1, 'Lactadherin binding agent': 1, 'T-cell surface glycoprotein CD3 epsilon chain cross-linking agent': 1, 'Collagen alpha-4(IV) chain inhibitor': 1, 'Connective tissue growth factor inhibitor': 1, 'Epidermal growth factor-like protein 7 inhibitor': 1, 'Epidermal growth factor receptor erbB1 cross-linking agent': 1, 'Ephrin type-A receptor 3 inhibitor': 1, 'Receptor tyrosine-protein kinase erbB-3 antagonist': 1, 'Fibronectin other': 1, 'Disialoganglioside GD2 cross-linking agent': 1, 'Claudin-18 binding agent': 1, 'Proheparin-binding EGF-like growth factor inhibitor': 1, 'Genome polyprotein inhibitor': 1, 'Hepcidin inhibitor': 1, 'HLA class II histocompatibility antigen, DRB1-10 beta chain other': 1, 'Inducible T-cell costimulator inhibitor': 1, 'Interleukin-10 inhibitor': 1, 'Interleukin-15 inhibitor': 1, 'CD44 antigen inhibitor': 1, 'Intercellular adhesion molecule 3 inhibitor': 1, 'T-cell differentiation antigen CD6 binding agent': 1, 'Selectin E inhibitor': 1, 'P-selectin inhibitor': 1, 'CD70 antigen cross-linking agent': 1, 'Transferrin receptor protein 1 antagonist': 1, 'Transferrin receptor inhibitor': 1, 'Killer cell immunoglobulin-like receptor 2DL2 inhibitor': 1, 'Killer cell immunoglobulin-like receptor 2DL1 inhibitor': 1, 'Tumor necrosis factor receptor superfamily member 3 agonist': 1, 'Mucosal addressin cell adhesion molecule-1 inhibitor': 1, 'Melanin binding agent': 1, 'Cell surface glycoprotein MUC18 inhibitor': 1, 'Osteopontin inhibitor': 1, 'Oxidized LDL inhibitor': 1, 'Cadherin-3 inhibitor': 1, 'Placenta growth factor inhibitor': 1, 'Poly-N-acetylglucosamine binding agent': 1, 'Proteoglycan chondroitin sulfate-associated protein binding agent': 1, 'Prostate stem cell antigen inhibitor': 1, 'Glutamate carboxypeptidase II other': 1, 'Parathyroid hormone-related protein inhibitor': 1, 'RAAG12 inhibitor': 1, 'ABC transporter GrfA inhibitor': 1, 'Sphingosine 1-phosphate inhibitor': 1, 'Choline transporter-like protein 4 binding agent': 1, 'Teratocarcinoma-derived growth factor 1 binding agent': 1, 'Tumor-associated antigen 72 inhibitor': 1, 'Tumor necrosis factor receptor R1 inhibitor': 1, 'T-cell receptor antagonist': 1, 'Tumor susceptibility gene 101 protein inhibitor': 1, 'Vascular endothelial growth factor receptor 3 inhibitor': 1, 'Interleukin-18 cross-linking agent': 1, 'Interleukin-1 receptor inhibitor': 1, 'Matrix protein 2 inhibitor': 1, 'Integrin alpha-V/beta-1 inhibitor': 1, 'Fibronectin receptor alpha inhibitor': 1, 'Integrin alpha-V/beta-6 inhibitor': 1, 'E protein inhibitor': 1, 'Urushiol inhibitor': 1, 'Vitronectin receptor alpha binding agent': 1, 'Growth/differentiation factor 2 inhibitor': 1, 'Lysyl oxidase homolog 2 inhibitor': 1, 'VEGF-A mRNA RNAi inhibitor': 1, 'Muscarinic acetylcholine receptor M3 partial agonist': 1, '26S proteasome inhibitor': 1, 'Sphingosine kinase 2 inhibitor': 1, 'Metalloproteinase inhibitor': 1, 'Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform inhibitor': 1, 'Membrane disrupting agent': 1, 'Cleavage and polyadenylation specificity factor subunit inhibitor': 1, 'Human immunodeficiency virus type 1 Tat protein antagonist': 1, 'Reverse transcriptase negative allosteric modulator': 1, 'Diacylglycerol O-acyltransferase 1 inhibitor': 1, 'Histone deacetylase 6 inhibitor': 1, 'Platelet-derived growth factor receptor alpha inhibitor': 1, 'Frizzled-1 antagonist': 1, 'Interferon-alpha/beta receptor alpha chain antagonist': 1, 'Endosialin inhibitor': 1, 'Surfactant': 1, 'Toll-like receptor 7 activator': 1, 'Serotonin 1f (5-HT1f) receptor agonist': 1, 'cIAP1/cIAP2 inhibitor': 1, 'Fast skeletal troponin complex activator': 1, 'Cholesterol ester hydrolytic enzyme': 1, 'C-X-C chemokine receptor type 4 inhibitor': 1, 'Mucin-1 vaccine antigen': 1, 'Transforming growth factor beta inhibitor': 1, 'FAD-dependent decaprenylphosphoryl-beta-D-ribofuranose 2-oxidase inhibitor': 1, 'Phosphodiesterase isozyme 4 inhibitor': 1, 'Serine/threonine-protein kinase PAK 4 inhibitor': 1, 'Nucleoprotein mRNA RNAi inhibitor': 1, 'CD27 antigen agonist': 1, 'Activin receptor type-2B antagonist': 1, 'T-cell-specific surface glycoprotein CD28 antagonist': 1, 'Serotonin 1b (5-HT1b) receptor antagonist': 1, 'Cellular tumor antigen p53 stabiliser': 1, 'Probable protein-cysteine N-palmitoyltransferase porcupine inhibitor': 1, 'Cytidine deaminase inhibitor': 1, 'Ghrelin receptor inverse agonist': 1, 'Histone-lysine N-methyltransferase EZH2 inhibitor': 1, 'Platelet-derived growth factor subunit B inhibitor': 1, 'Frizzled-8 antagonist': 1, 'Interleukin-20 inhibitor': 1, 'B-cell antigen receptor complex-associated protein beta chain binding agent': 1, 'Rivaroxaban sequestering agent': 1, 'Neurogenic locus notch homolog protein 3 inhibitor': 1, 'Nectin-4 binding agent': 1, 'Metabotropic glutamate receptor 2 modulator': 1, 'Muscarinic acetylcholine receptor M2 positive allosteric modulator': 1, 'Carbepenem-hydrolyzing beta-lactamase KPC inhibitor': 1, 'Polymerase basic protein 2 inhibitor': 1, 'Metabotropic glutamate receptor 2 positive allosteric modulator': 1, 'Free fatty acid receptor 2 antagonist': 1, 'Acetyl-CoA carboxylase negative allosteric modulator': 1, 'Dopamine D1 receptor positive allosteric modulator': 1, 'Heparin sequestering agent': 1, 'Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 inhibitor': 1, 'Sodium channel protein type X alpha subunit blocker': 1, 'Vanilloid receptor inhibitor': 1, 'SOD mimic (antioxidant)': 1, 'Apolipoprotein C-III mRNA antisense inhibitor': 1, \"Apolipoprotein C-III mRNA 3'UTR antisense inhibitor\": 1, 'Dabigatran sequestering agent': 1, 'LXR-beta modulator': 1, 'Elastin proteolytic enzyme': 1, 'Ribosomal protein S6 kinase 1 inhibitor': 1, 'Serine/threonine-protein kinase RAF inhibitor': 1, 'Choline kinase alpha inhibitor': 1, 'Free fatty acid receptor 1 agonist': 1, 'Melanocortin receptor 3 agonist': 1, 'Neuropeptide Y receptor type 4 agonist': 1, 'Muscarinic acetylcholine receptor antagonist': 1, 'Retinoic acid receptor antagonist': 1, 'Calcium sensing receptor agonist': 1, 'Exportin-1 inhibitor': 1, 'Angiopoietin-related protein 3 inhibitor': 1, 'P2X purinoceptor 7 negative allosteric modulator': 1, 'c-Jun N-terminal kinase, JNK inhibitor': 1, 'Serotonin 7 (5-HT7) receptor antagonist': 1, 'Neurogenic locus notch homolog protein 1 inhibitor': 1, 'Cystic fibrosis transmembrane conductance regulator activator': 1, 'Fibroblast growth factor receptor 4 inhibitor': 1, 'ATP-citrate synthase inhibitor': 1, 'MAP kinase-activated protein kinase 5 inhibitor': 1, 'Proto-oncogene Mas agonist': 1, 'Nuclear receptor ROR-gamma antagonist': 1, 'CD276 antigen cross-linking agent': 1, 'Leucine--tRNA ligase inhibitor': 1, 'Estrogen receptor alpha antagonist': 1, 'Voltage-gated T-type calcium channel alpha-1H subunit blocker': 1, 'Orexin receptor 2 antagonist': 1, 'Transient receptor potential cation channel subfamily M member 8 inhibitor': 1, 'Dopamine D1 receptor partial agonist': 1, 'Transient receptor potential cation channel subfamily V member 4 antagonist': 1, 'C-C chemokine receptor type 2 inhibitor': 1, 'Neuronal acetylcholine receptor protein alpha-7 subunit modulator': 1, 'Vascular endothelial growth factor A binding agent': 1, 'Retinoid isomerohydrolase positive modulator': 1, 'Atrial natriuretic peptide receptor B binding agent': 1, 'Globohexaosylceramide vaccine antigen': 1, 'Transient receptor potential cation channel subfamily M member 8 agonist': 1, 'Transient receptor potential cation channel subfamily V member 3 antagonist': 1, 'Fibroblast growth factor 23 inhibitor': 1, 'Neuronal acetylcholine receptor; alpha4/beta2 modulator': 1, 'Sphingomyelin hydrolytic enzyme': 1, 'Synaptosomal nerve-associated protein 25 (SNAP-25) inhibitor': 1, 'Glycosaminoglycans hydrolytic enzyme': 1, 'SMAD-7 mRNA antisense inhibitor': 1, 'P2X purinoceptor 3 antagonist': 1, 'Proteinase activated receptor 4 antagonist': 1, 'G-protein coupled receptor 84 negative allosteric modulator': 1, 'Nuclear factor NF-kappa-B complex inhibitor': 1, 'Autotaxin inhibitor': 1, 'Metalloreductase STEAP1 binding agent': 1, 'IL6Ralpha/GP130 antagonist': 1, 'C-type lectin domain family 4 member C inhibitor': 1, 'Alpha-synuclein inhibitor': 1, 'Cyanide sequestering agent': 1, 'SOD1 mRNA inhibitor': 1, 'Programmed cell death 1 ligand 1 other': 1, 'Opioid receptors; mu/kappa/delta agonist': 1, 'Coagulation factor IX and X other': 1, 'Dipeptidyl peptidase I inhibitor': 1, 'Prostanoid EP1 receptor antagonist': 1, 'Mitogen-activated protein kinase kinase kinase 5 inhibitor': 1, 'Mineralocorticoid receptor modulator': 1, 'Receptor-type tyrosine-protein phosphatase beta inhibitor': 1, 'Monoglyceride lipase inhibitor': 1, 'LPS-assembly protein LptD inhibitor': 1, 'Sunscreen/skin protectant': 1, 'Calcium chelating agent': 1, 'Sarcoplasmic/endoplasmic reticulum calcium ATPase inhibitor': 1, 'C5a anaphylatoxin chemotactic receptor antagonist': 1, 'CRL4(CRBN) E3 ubiquitin ligase modulator': 1, 'Advanced glycosylation end product-specific receptor antagonist': 1, 'NACHT, LRR and PYD domains-containing protein 3 inhibitor': 1, 'Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase 1 activator': 1, 'Selectin E antagonist': 1, 'Phosphodiesterase 10A inhibitor': 1, 'Growth factor receptor-bound protein 2 mRNA antisense inhibitor': 1, 'Beta-lactam antibiotics hydrolytic enzyme': 1, 'Alpha-hemolysin inhibitor': 1, 'Melanoma-associated antigen 3 vaccine antigen': 1, 'Delta-like protein 3 binding agent': 1, \"5'-nucleotidase inhibitor\": 1, 'RSPO3-LGR4 inhibitor': 1, 'PCSK9 mRNA RNAi inhibitor': 1, 'Coagulation factor IX positive modulator': 1, 'Cell therapy': 1, 'Helicase/primase inhibitor': 1, 'Tryptophan 5-hydroxylase 1 inhibitor': 1, 'MAP kinase-interacting serine/threonine-protein kinase 1/2 inhibitor': 1, 'Interleukin-1 receptor-associated kinase 4 inhibitor': 1, 'Metabotropic glutamate receptor 4 positive allosteric modulator': 1, 'Hemoglobin HbA positive modulator': 1, 'IDH1/IDH2 inhibitor': 1, 'Nicotinic acetylcholine receptor agonist': 1, 'Heparanase inhibitor': 1, 'Peptidoglycan disrupting agent': 1, 'Antifoaming agent': 1, 'Synaptosomal-associated protein 25 proteolytic enzyme': 1, 'Survival motor neuron protein positive modulator': 1, 'Beta amyloid A4 protein disrupting agent': 1, 'Lysophosphatidic acid receptor Edg-2 antagonist': 1, 'Metalloporphyrin antioxidant (antitumor, radioprotectant)': 1, 'Lysine-specific histone demethylase 1 inhibitor': 1, 'Serine/threonine protein phosphatase 2A, catalytic subunit, alpha isoform inhibitor': 1, 'Translocator protein antagonist': 1, 'Coagulation factor VII inhibitor': 1, 'Proteinase-activated receptor 1 inhibitor': 1, 'Serine/threonine-protein kinase AKT negative allosteric modulator': 1, 'Toll-like receptor 2 inhibitor': 1, 'Cap binding complex modulator': 1, 'Methionine--tRNA ligase inhibitor': 1, 'NAD-dependent deacetylase sirtuin 1 activator': 1, 'Interleukin-8 receptors, CXCR1/CXCR2 inhibitor': 1, 'Sphingosine 1-phosphate receptor Edg-1 modulator': 1, 'Mercury sequestering agent': 1, 'Aminopeptidase A inhibitor': 1, 'Modulates mitochondrial respiratory chain and ROS': 1, 'DNA negative modulator': 1, 'Transthyretin mRNA antisense inhibitor': 1, 'Interleukin-33 binding agent': 1, 'Huntingtin mRNA antisense inhibitor': 1, 'Potassium-transporting ATPase blocker': 1, 'GPI-anchored wall transfer protein 1 inhibitor': 1, 'Helicase primate complex inhibitor': 1, 'Myeloperoxidase inhibitor': 1, 'Chymase inhibitor': 1, 'Leukotriene A4 hydrolase inhibitor': 1, 'Dihydroorotate dehydrogenase (quinone), mitochondrial inhibitor': 1, 'Molecule (9-cis-retinol) replacement': 1, 'Cathepsin S inhibitor': 1, 'Envelope protein inhibitor': 1, 'Stimulator of interferon genes protein agonist': 1, 'Platelet glycoprotein Ib alpha chain antagonist': 1, 'Alginate polysaccharide binding agent': 1, 'Fucosyl-GM1 binding agent': 1, 'Bile acid transporter inhibitor': 1, 'Macrophage colony stimulating factor receptor antagonist': 1, 'Complement C5 mRNA RNAi inhibitor': 1, 'Inactive tyrosine-protein kinase transmembrane receptor ROR1 inhibitor': 1, 'Interleukin-6 binding agent': 1, 'P-selectin blocker': 1, 'CD166 antigen binding agent': 1, 'Repulsive guidance molecule A inhibitor': 1, 'Antithrombin mRNA RNAi inhibitor': 1, 'Calcitonin gene-related peptide antagonist': 1, 'Ribonucleotide reductase small subunit mRNA antisense inhibitor': 1, 'Lubricant and shock absorber': 1, 'Transthyretin ANTISENSE inhibitor': 1, 'Protein kinase C epsilon inhibitor': 1, 'NKG2-A/NKG2-B type II integral membrane protein inhibitor': 1, 'Sialyl Lewis A (CA19-9) binding agent': 1, 'Triggering receptor expressed on myeloid cells 1 inhibitor': 1, 'Interleukin-31 receptor subunit alpha inhibitor': 1, 'Interleukin-21 binding agent': 1, 'Phenylalanine hydrolytic enzyme': 1, 'Trophoblast glycoprotein binding agent': 1, 'Interferon beta inhibitor': 1, 'CBP/beta catenin inhibitor': 1, 'Oxalate hydrolytic enzyme': 1, 'Interferon alpha/beta receptor positive modulator': 1, 'RNA hydrolytic enzyme': 1, 'Complement C1s inhibitor': 1, 'Lymphocyte differentiation antigen CD38 binding agent': 1, 'Gastric inhibitory polypeptide receptor agonist': 1, 'Neurotrophic tyrosine kinase receptor agonist': 1, 'P-selectin glycoprotein ligand 1 inhibitor': 1, 'Sialic acid-binding Ig-like lectin 8 inhibitor': 1, 'Photosensitiser': 1, 'Semaphorin-4D inhibitor': 1, 'Tumor necrosis factor ligand superfamily member 6 binding agent': 1, 'Angiotensinogen hydrolytic enzyme': 1, 'CD70 antigen inhibitor': 1, 'Coagulation factor XI negative allosteric modulator': 1, 'Peptidoglycan hydrolytic enzyme': 1, 'Interleukin 17A binding agent': 1, 'Leukotriene B4 receptor inhibitor': 1, 'Glycosaminoglycans binding agent': 1, 'Fractalkine inhibitor': 1, 'Glucagon-like peptide 1 receptor antagonist': 1, 'Galectin-1 inhibitor': 1, 'Serum amyloid P-component inhibitor': 1, 'Antibodies hydrolytic enzyme': 1, 'Leukocyte surface antigen CD47 inhibitor': 1, 'Melanocyte protein PMEL binding agent': 1, 'Killer cell immunoglobulin-like receptor 3DL2 antagonist': 1, 'High mannose oligosaccharides hydrolytic enzyme': 1, 'Complement C5 binding agent': 1, 'Hemagglutinin binding agent': 1, 'Releases NO, antimicrobial': 1, 'Toll-like receptor 2 antagonist': 1, 'Alpha-synuclein binding agent': 1, 'Glypican-3 inhibitor': 1, 'IL-2R beta/gamma binding agent': 1, 'Beta-2 adrenergic receptor mRNA RNAi inhibitor': 1, 'T-cell surface antigen CD4 binding agent': 1, 'B-lymphocyte antigen CD19 inhibitor': 1, 'Cholesterol 24-hydroxylase inhibitor': 1, 'Coagulation factor VIII positive modulator': 1, 'Mannan-binding lectin serine protease 2 inhibitor': 1, 'Hydrochloric acid sequestering agent': 1, 'Phosphodiesterase 4D inhibitor': 1, 'B-raf/RAF proto-oncogene serine/threonine-protein kinase inhibitor': 1, 'Endothelial PAS domain-containing protein 1 inhibitor': 1, 'Ultrasound contrast agent': 1, 'Hemoglobin beta chain positive modulator': 1, 'Glycogen hydrolytic enzyme': 1, 'L-lactate dehydrogenase A chain mRNA RNAi inhibitor': 1, 'Oncostatin-M-specific receptor subunit beta inhibitor': 1, 'Tumor necrosis factor receptor superfamily member 13C binding agent': 1, 'Envelope glycoprotein binding agent': 1, 'Structural capsid protein inhibitor': 1, 'Dopamine beta-hydroxylase inhibitor': 1, 'Complement factor B inhibitor': 1, 'C5a anaphylatoxin chemotactic receptor inhibitor': 1, 'CEP290 mRNA positive modulator': 1, 'Leukocyte antigen CD37 inhibitor': 1, 'Syncytin-1 inhibitor': 1, \"H-Ras mRNA 5'UTR antisense inhibitor\": 1, 'Protransforming growth factor alpha inhibitor': 1, 'Receptor tyrosine-protein kinase erbB-3 binding agent': 1, 'Receptor protein-tyrosine kinase erbB-2 negative allosteric modulator': 1, 'Enhanced NK cells': 1, 'Fibroblast growth factor receptor 2 binding agent': 1, 'Tyrosine-protein kinase receptor FLT3 binding agent': 1, 'Tyrosine-protein kinase receptor FLT3 agonist': 1, 'Platelet glycoprotein VI (GPVI) inhibitor': 1, 'LPA mRNA rnai inhibitor': 1, 'Interleukin-15 receptor agonist': 1, 'ADM stabiliser': 1, 'VEGFR1 mRNA rnai inhibitor': 1, 'Granulocyte colony stimulating factor receptor antagonist': 1, 'mRNA antisense inhibitor': 1, 'Protein-tyrosine phosphatase 2C inhibitor': 1})\n"
          ]
        }
      ],
      "source": [
        "from collections import Counter\n",
        "\n",
        "count=Counter(mechanism_of_action)\n",
        "print(\"Order of the most equal action mechanism :\" ,count)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "9a2969f7",
      "metadata": {
        "id": "9a2969f7",
        "outputId": "288cd4ef-4bd6-4c1e-e8e4-c2fb38b262ad"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "The most equal action mechanism :  [('Unknown', 177)]\n"
          ]
        }
      ],
      "source": [
        "count=Counter(mechanism_of_action)\n",
        "print(\"The most equal action mechanism : \" , count.most_common(1)) "
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "df4e79f2",
      "metadata": {
        "id": "df4e79f2",
        "outputId": "edb57a2c-9af1-4276-e244-d3be0e07837c"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Three of the most equal action mechanisms : [('Unknown', 177), ('Glucocorticoid receptor agonist', 57), ('DNA inhibitor', 46)]\n"
          ]
        }
      ],
      "source": [
        "count=Counter(mechanism_of_action)\n",
        "count=Counter(mechanism_of_action)\n",
        "print(\"Three of the most equal action mechanisms :\" , count.most_common(3))"
      ]
    }
  ],
  "metadata": {
    "kernelspec": {
      "display_name": "Python 3 (ipykernel)",
      "language": "python",
      "name": "python3"
    },
    "language_info": {
      "codemirror_mode": {
        "name": "ipython",
        "version": 3
      },
      "file_extension": ".py",
      "mimetype": "text/x-python",
      "name": "python",
      "nbconvert_exporter": "python",
      "pygments_lexer": "ipython3",
      "version": "3.10.8"
    },
    "colab": {
      "provenance": []
    }
  },
  "nbformat": 4,
  "nbformat_minor": 5
}